Matthew Lee is an associate in Goodwin’s Technology and Life Sciences group in London. Mr. Lee advises clients on a broad range of corporate matters, with a focus on transactions in the life sciences, healthcare and technology sectors. He has particular experience advising on mergers and acquisitions, corporate finance and  capital markets transactions, as well as general corporate matters.

Prior to joining Goodwin, Mr. Lee was an associate in the Corporate Finance and M&A department at Bryan Cave Leighton Paisner LLP.

Areas of Practice
Domaines D’Expertise





Mr. Lee’s representative experience includes:

  • Quanta Dialysis Technologies on multiple private funding rounds including its most recent $245 million oversubscribed Series D funding round, the largest private funding round for a dialysis device company in history.
  • Achilles Therapeutics plc on its Initial Public Offering on NASDAQ with total proceeds of $175.5 million. Achilles is a biopharmaceutical company developing personalised cancer immunotherapies. 
  • Achilles Therapeutics on the completion of its £52.7 million Series C. 
  • COMPASS Pathways plc on its public follow-on offering on NASDAQ of American Depositary Shares for gross proceeds of approximately $144 million.
  • COMPASS Pathways plc on its $146.6 million initial public offering on NASDAQ. Compass is a life sciences company dedicated to accelerating patient access to evidence based innovation in mental health.
  • Rockend Limited, a company aiming to create novel cell therapeutics on its seed financing and subsequent seed extension financing.
  • Wintermute Trading Limited, a leading global crypto market maker, on their $20 million Series B funding round.
  • Wintermute Trading Limited on its $2.8 million Series A financing.

In The News









Legal Practice Course, 2016
BPP Law School
LL.B., 2014
University of York



Solicitor of the Senior Courts of England and Wales
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.


Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Search Other Lawyers
Recherche par Pratique